• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声特征鉴别早期卵巢透明细胞癌与不典型表现的子宫内膜异位囊肿。

Sonographic features differentiating early-stage ovarian clear cell carcinoma from endometrioma with atypical features.

机构信息

National Taiwan University Hospital, Yunlin Branch, Yunlin county, Taiwan.

Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

出版信息

J Ovarian Res. 2022 Jul 14;15(1):84. doi: 10.1186/s13048-022-01019-8.

DOI:10.1186/s13048-022-01019-8
PMID:35836288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9284754/
Abstract

BACKGROUND

Ovarian clear cell carcinoma (OCCC) is the most common endometriosis-associated ovarian cancer. Ovarian endometriosis may present with atypical or malignant sonographic features and interfere with clinical judgment about whether definitive surgical intervention is required.

OBJECTIVE

To compare the characteristics of endometrioma with atypical features and OCCC.

METHODS

This study enrolled patients with pathologic diagnoses of either endometrioma or OCCC. For patients with endometrioma, only those with atypical features, defined as the presence of at least one of the following sonographic characteristics: cyst diameter of 10 ± 1 cm, multi-cystic lesions, any solid component or papillary structure, and blood flow of any degree, were included.

RESULTS

Sixty-three patients had endometriomas with atypical features, while 57 patients had OCCC. Patients with endometriomas were younger (39.33 ± 7.04 years vs. 53.11 ± 9.28 years, P < 0.01), had smaller cysts (7.81 ± 2.81 cm vs. 12.68 ± 4.60 cm, P < 0.01), and had smaller solid components (0.93 ± 1.74 cm vs. 4.82 ± 3.53 cm, P < 0.01). In contrast, OCCCs were associated with loss of ground-glass echogenicity (6.3% vs 68.4%, P < 0.01). In multivariate analysis, advanced age (> 47.5 years), large cysts (> 11.55 cm), large solid components (size > 1.37 cm), and loss of ground-glass echogenicity were independent factors suggestive of malignancy.

CONCLUSION

Advanced age, larger cyst sizes, larger solid component sizes, and loss of ground-glass echogenicity are major factors differentiating endometriomas from malignancies. For women in menopausal transition who have finished childbearing who present with endometrioma with atypical features, removal of the adnexa intact could be considered.

摘要

背景

卵巢透明细胞癌(OCCC)是最常见的子宫内膜异位症相关卵巢癌。卵巢子宫内膜异位症可能表现出非典型或恶性的超声特征,并干扰临床判断是否需要明确的手术干预。

目的

比较具有非典型特征的卵巢子宫内膜异位囊肿和 OCCC 的特征。

方法

本研究纳入了病理诊断为卵巢子宫内膜异位囊肿或 OCCC 的患者。对于卵巢子宫内膜异位囊肿患者,仅纳入具有以下至少一种超声特征的非典型特征的患者:囊肿直径为 10±1cm、多房性病变、任何实性成分或乳头状结构、以及任何程度的血流。

结果

63 例患者的卵巢子宫内膜异位囊肿具有非典型特征,而 57 例患者患有 OCCC。具有卵巢子宫内膜异位囊肿的患者年龄更小(39.33±7.04 岁 vs. 53.11±9.28 岁,P<0.01),囊肿更小(7.81±2.81cm vs. 12.68±4.60cm,P<0.01),实性成分更小(0.93±1.74cm vs. 4.82±3.53cm,P<0.01)。相比之下,OCCC 与玻璃样回声丢失有关(6.3% vs 68.4%,P<0.01)。多因素分析显示,年龄较大(>47.5 岁)、较大的囊肿(>11.55cm)、较大的实性成分(大小>1.37cm)和玻璃样回声丢失是提示恶性的独立因素。

结论

年龄较大、较大的囊肿大小、较大的实性成分大小和玻璃样回声丢失是区分卵巢子宫内膜异位囊肿和恶性肿瘤的主要因素。对于处于绝经过渡阶段、已完成生育且具有非典型特征的卵巢子宫内膜异位囊肿患者,可以考虑完整切除附件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19f6/9284754/972b1edfa4c2/13048_2022_1019_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19f6/9284754/7b76f1885a0e/13048_2022_1019_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19f6/9284754/972b1edfa4c2/13048_2022_1019_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19f6/9284754/7b76f1885a0e/13048_2022_1019_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19f6/9284754/972b1edfa4c2/13048_2022_1019_Fig2_HTML.jpg

相似文献

1
Sonographic features differentiating early-stage ovarian clear cell carcinoma from endometrioma with atypical features.超声特征鉴别早期卵巢透明细胞癌与不典型表现的子宫内膜异位囊肿。
J Ovarian Res. 2022 Jul 14;15(1):84. doi: 10.1186/s13048-022-01019-8.
2
Age-related differences in the sonographic characteristics of endometriomas.子宫内膜异位囊肿超声特征的年龄相关差异。
Hum Reprod. 2016 Aug;31(8):1723-31. doi: 10.1093/humrep/dew113. Epub 2016 Jun 9.
3
Ovarian endometriosis during pregnancy: a series of 53 endometriomas.妊娠期卵巢子宫内膜异位症:53例子宫内膜瘤病例系列
Eur J Obstet Gynecol Reprod Biol. 2017 Feb;209:100-104. doi: 10.1016/j.ejogrb.2015.09.037. Epub 2015 Oct 9.
4
Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma.妇科疾病影像学(十四):卵巢透明细胞癌的临床和超声特征。
Ultrasound Obstet Gynecol. 2018 Dec;52(6):792-800. doi: 10.1002/uog.19171.
5
[Ovarian clear cell carcinoma derived from endometriotic cyst: a clinicopathological analysis of 54 cases].[来源于子宫内膜异位囊肿的卵巢透明细胞癌:54例临床病理分析]
Zhonghua Fu Chan Ke Za Zhi. 2015 Nov;50(11):838-42.
6
Imaging in gynecological disease. 10: Clinical and ultrasound characteristics of decidualized endometriomas surgically removed during pregnancy.妇科疾病的影像学检查。10:孕期手术切除的蜕膜样子宫内膜瘤的临床及超声特征
Ultrasound Obstet Gynecol. 2014 Sep;44(3):354-60. doi: 10.1002/uog.13323.
7
Clinical characteristics of patients in Japan with ovarian cancer presumably arising from ovarian endometrioma.日本疑似起源于卵巢子宫内膜异位症的卵巢癌患者的临床特征。
Gynecol Obstet Invest. 2014;77(2):104-10. doi: 10.1159/000357819. Epub 2014 Feb 5.
8
Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma.卵巢子宫内膜异位症对卵巢透明细胞癌预后的意义
Int J Gynecol Cancer. 2018 Jan;28(1):11-18. doi: 10.1097/IGC.0000000000001136.
9
Ovarian carcinoma in patients with endometriosis: MR imaging findings.子宫内膜异位症患者的卵巢癌:磁共振成像表现
AJR Am J Roentgenol. 2000 Nov;175(5):1423-30. doi: 10.2214/ajr.175.5.1751423.
10
Laparoscopic removal of endometriomas: sonographic evaluation of residual functioning ovarian tissue.腹腔镜下切除子宫内膜异位囊肿:残余功能性卵巢组织的超声评估
Am J Obstet Gynecol. 2004 Jul;191(1):68-72. doi: 10.1016/j.ajog.2004.01.010.

引用本文的文献

1
Head to toe: expand your diagnosis on routine imaging to include endometriosis.从头到脚:在常规影像学检查中扩展诊断范围,将子宫内膜异位症纳入其中。
Abdom Radiol (NY). 2025 Jun 20. doi: 10.1007/s00261-025-05051-2.
2
Endometriosis: assessment on O-RADS and risk of malignant transformation.子宫内膜异位症:O-RADS评估及恶变风险
Abdom Radiol (NY). 2025 Mar 26. doi: 10.1007/s00261-025-04885-0.
3
Research progress in endometriosis-associated ovarian cancer.子宫内膜异位症相关卵巢癌的研究进展

本文引用的文献

1
Stepwise Approach to the Management of Endometriosis-Related Dysmenorrhea: A Cost-Effectiveness Analysis.内异症相关痛经管理的分步方法:成本效益分析。
Obstet Gynecol. 2021 Oct 1;138(4):557-564. doi: 10.1097/AOG.0000000000004536.
2
Dienogest and the Risk of Endometriosis Recurrence Following Surgery: A Systematic Review and Meta-analysis.地诺孕素治疗术后子宫内膜异位症复发的风险:系统评价和荟萃分析。
J Minim Invasive Gynecol. 2020 Nov-Dec;27(7):1503-1510. doi: 10.1016/j.jmig.2020.05.007. Epub 2020 May 16.
3
Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts.
Front Oncol. 2024 Apr 25;14:1381244. doi: 10.3389/fonc.2024.1381244. eCollection 2024.
4
Endometriosis-Related Ovarian Cancer: Where Are We Now? A Narrative Review towards a Pragmatic Approach.子宫内膜异位症相关的卵巢癌:我们目前的状况如何?一篇关于务实方法的叙述性综述。
J Clin Med. 2024 Mar 27;13(7):1933. doi: 10.3390/jcm13071933.
5
At what age endometriosis-associated ovarian cancer is diagnosed? The implications for women in the reproductive age.子宫内膜异位症相关的卵巢癌在什么年龄被诊断出来?对育龄期女性的影响。
Front Oncol. 2023 May 23;13:1193123. doi: 10.3389/fonc.2023.1193123. eCollection 2023.
6
A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment.子宫内膜异位症的终身影响:发病机制与药物治疗。
Int J Mol Sci. 2023 Apr 19;24(8):7503. doi: 10.3390/ijms24087503.
7
Endometriosis-Associated Ovarian Cancer: What Are the Implications for Women with Intact Endometrioma Planning for a Future Pregnancy? A Reproductive Clinical Outlook.子宫内膜异位症相关卵巢癌:对有完整子宫内膜异位瘤且计划未来妊娠的女性有何影响?生殖临床展望。
Biomolecules. 2022 Nov 21;12(11):1721. doi: 10.3390/biom12111721.
子宫内膜异位症相关卵巢癌发生在子宫内膜囊肿随访的早期。
Int J Clin Oncol. 2020 Jan;25(1):51-58. doi: 10.1007/s10147-019-01536-5. Epub 2019 Aug 31.
4
Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated?围绝经期卵巢子宫内膜异位症的管理和相关的癌症风险:何时需要进行药物或手术治疗?
Best Pract Res Clin Obstet Gynaecol. 2018 Aug;51:151-168. doi: 10.1016/j.bpobgyn.2018.01.017. Epub 2018 Feb 15.
5
Clinical Management of Endometriosis.子宫内膜异位症的临床管理。
Obstet Gynecol. 2018 Mar;131(3):557-571. doi: 10.1097/AOG.0000000000002469.
6
Factors that Differentiate between Endometriosis-associated Ovarian Cancer and Benign Ovarian Endometriosis with Mural Nodules.区分卵巢子宫内膜异位症相关卵巢癌与伴壁结节的良性卵巢子宫内膜异位症的因素。
Magn Reson Med Sci. 2018 Jul 10;17(3):231-237. doi: 10.2463/mrms.mp.2016-0149. Epub 2017 Aug 21.
7
Predictive factors of ovarian carcinoma for women with ovarian endometrioma aged 45 years and older in China.中国45岁及以上卵巢子宫内膜异位症女性卵巢癌的预测因素。
J Ovarian Res. 2017 Jul 17;10(1):45. doi: 10.1186/s13048-017-0343-2.
8
Unexpected epithelial ovarian cancers arising from presumed endometrioma: A 10-year retrospective analysis.源自假定子宫内膜异位囊肿的意外上皮性卵巢癌:一项10年回顾性分析。
Taiwan J Obstet Gynecol. 2017 Feb;56(1):55-61. doi: 10.1016/j.tjog.2015.09.009.
9
Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women.美国确诊子宫内膜异位症的患病率及症状负担:基于对59411名女性的横断面调查的全国估计数
Gynecol Obstet Invest. 2017;82(5):453-461. doi: 10.1159/000452660. Epub 2016 Nov 8.
10
Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review.子宫内膜异位症女性上皮性卵巢癌的危险因素:一项系统评价
Acta Obstet Gynecol Scand. 2017 Jun;96(6):761-778. doi: 10.1111/aogs.13010. Epub 2016 Oct 2.